Skip to main content
. 2019 Sep 12;10:2170. doi: 10.3389/fimmu.2019.02170

Figure 2.

Figure 2

miR-142-3p is overexpressed in MTregs from GPA patients in remission and is differentially regulated in CD4+T cell subsets. miR-142-3p levels were significantly higher in MTregs from GPA patients (GPA) than in those from healthy controls (HC) (A). miR-142-3p levels were significantly lower in MTregs than in NTregs (B) and in CD4+TNAVE and CD4+TEM cells from HC (circles) and GPA patients (squares) (C). Stimulation of MTregs and NTregs with anti-CD3-CD28 Dynabeads led to significantly lower miR-142-3p levels over time (n = 5) (D). *P = 0.05–0.01, **P = 0.01–0.001.